Reverse chamber remodelling following adrenergic-induced advanced cardiac dilatation and pump dysfunction

Basic Research in Cardiology

Volumn 107, Issue 1, 2012, Pages

  Booysen, Hendrik L ^a   Norton, Gavin R ^a   Opie, Lionel H ^b   Woodiwiss, Angela J ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Adrenergic activation; Apoptosis; Cardiac dilatation; Pump dysfunction

Indexed keywords

BETA ADRENERGIC RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; MALE; NONHUMAN; RAT; RECEPTOR UPREGULATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; APOPTOSIS; CARDIOMYOPATHY, DILATED; ISOPROTERENOL; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 83655172386     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-011-0238-0     Document Type: Article

References (41)

1. D Angert RM Berretta H Kubo H Zhang X Chen W Wang B Ogorek M Barbe SR Houser 2011 Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells Circ Res 108 1226 1237 10.1161/CIRCRESAHA.110.239046 21454756 10.1161/CIRCRESAHA.110.239046 1:CAS:528:DC%2BC3MXlvFGhtLk%3D
2. S Argawala RE Kalil 1998 Axotomy-induced neuronal death and reactive astrogliosis in the lateral geniculate nucleus following a lesion of the visual cortex in the rat J Comp Neurol 392 252 263 10.1002/(SICI)1096-9861(19980309) 392:2<252::AID-CNE7>3.0.CO;2-1 10.1002/(SICI)1096-9861(19980309)392: 2<252::AID-CNE7>3.0.CO;2-1 (Pubitemid 28093922)
3. A Barbone MC Oz D Burkhoff JW Holmes 2001 Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry Circulation 104 I229 I232 10.1161/hc37t1.094914 11568061 10.1161/hc3101.093903 1:STN:280:DC%2BD3MritFyltQ%3D%3D (Pubitemid 32884808)
4. D Bello DJ Shah GM Faragh S Di Luzio M Parker MR Johnson WG Cottss FJ Klocker RO Bonow RM Judd M Gheorghiade RJ Kim 2003 Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 1945 1953 10.1161/01.CIR.0000095029.57483.60 14557364 10.1161/01.CIR.0000095029. 57483.60 1:CAS:528:DC%2BD3sXotVeisr8%3D (Pubitemid 37296539)
5. MR Bristow EM Gilbert WT Abraham KF Adams MB Fowler RE Hershberger SH Kubo KA Narahara H Ingersoll S Krueger S Young N Shusterman 1996 Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circulation 94 2807 2816 8941106 1:CAS:528:DyaK2sXlsVShuw%3D%3D (Pubitemid 26411745)
6. S Capomolla O Febo M Gnemmi G Riccardi C Opasich A Caporotondi A Mortara GD Pinna F Cobelli 2000 Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol Am Heart J 139 596 608 10.1016/S0002-8709(00)90036-X 10740140 10.1016/S0002-8703(00)90036- X 1:CAS:528:DC%2BD3cXjtVamsLw%3D (Pubitemid 30207784)
7. Chan V, Fenning A (2011) Chronic beta-adrenoceptor antagonist treatment controls cardiovascular remodelling in heart failure in the ageing spontaneously hypertensive rat: metoprolol and cardiovascular changes in SHR. J Cardiovasc Pharmacol. doi: 10.1097/FJC.0b013e3182283c78 (online before print)
8. G Chen X Zhou S Florea J Qian W Cai Z Zhang G-C Fan j Lorenz j Lorenz RJ Hajjar EG Kranias 2010 Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis Basic Res Cardiol 105 573 581 10.1007/s00395-010-0106-3 20512582 10.1007/s00395-010-0106-3 1:CAS:528:DC%2BC3cXpslClsrY%3D
9. JN Cohn R Ferrari N Sharpe 2000 Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. On behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 569 582 10.1016/S35-1097(99)00630-0 10716457 10.1016/S0735-1097(99) 00630-0 1:STN:280:DC%2BD3c7nvFajsw%3D%3D (Pubitemid 30167013)
10. RN Doughty GA Whalley G Gamble S MacMahon N Sharpe 1997 Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group J Am Coll Cardiol 29 1060 1066 10.1016/S0735-1097(97)00012-0 9120160 10.1016/S0735-1097(97)00012-0 1:CAS:528:DyaK2sXislamsbw%3D (Pubitemid 27149582)
11. M Egred S Shaw B Mohammad P Waitt E Rodrigues 2005 Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease QJM 98 493 497 10.1093/qjmed/hci080 15955798 10.1093/qjmed/hci080 1:STN:280:DC%2BD2MzksVSntg%3D%3D (Pubitemid 41418672)
12. MB Fowler SR Lottes JJ Nelson MA Lukas EM Gilbert B Greenberg BM Massie WT Abraham JA Franciosa 2007 Beta-blocker dosing in community-based treatment of heart failure Am Heart J 153 1029 1036 10.1016/j.ahj.2007.03.010 17540206 10.1016/j.ahj.2007.03.010 1:CAS:528:DC%2BD2sXmtVaqs74%3D (Pubitemid 46809843)
13. Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD (2011). Tumour necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol. doi: 10.1007/s00395-011-0196-6 (E-pub ahead of print)
14. RT Gan WM Li CH Xiu JX Shen X Wang S Wu YH Kong 2007 Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure Chin Med J (Engl) 120 2250 2255 1:CAS:528:DC%2BD1cXht12ltLc%3D
15. BA Groenning JC Nilsson L Sondergaard T Fritz-Hansen HB Larsson PR Hildebrandt 2000 Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure J Am Coll Cardiol 36 2072 2080 10.1016/S0735-1097(00)01006-8 11127443 10.1016/S0735-1097(00)01006-8 1:CAS:528:DC%2BD3cXptFSqtL0%3D
16. SA Hall CG Cigarroa L Marcoux RC Risser PA Grayburn EJ Eichhorn 1995 Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1154 1161 10.1016/0735-1097(94)00543-Y 7897129 10.1016/0735-1097(94)00543-Y 1:STN:280:DyaK2M3gsVyhsA%3D%3D
17. LC Heather AF Catchpole DJ Stuckey MA Cole CA Carr K Clarke 2009 Isoproterenol induces in vivo functional and metabolic abnormalities; similar to those found in the infarcted rat heart J Physiol Pharm 60 31 39 1:CAS:528:DC%2BD1MXhsVeht7bM
18. K Hu P Gaudron G Ertl 1998 Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size J Am Coll Cardiol 31 692 700 10.1016/S0735-1097(97)00527-5 9502655 10.1016/S0735-1097(97)00527-5 1:CAS:528:DyaK1cXhvVyksrc%3D (Pubitemid 28144139)
19. SA Hunt WT Abraham MH Chin AM Feldman GS Francis TG Ganiats M Jessup MA Konstam DM Mancini K Michl JA Oates PS Rahko MA Silver L Warner Stevenson CW Yancy 2009 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults Circulation 119 e391 e479 10.1161/CIRCULATIONAHA.109.192065 19324966 10.1161/CIRCULATIONAHA.109. 192065
20. J Kluger RJ Cody JH Laragh 1982 The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril) Am J Cardiol 49 1667 1674 10.1016/0002-9149(82)90244-2 7044087 10.1016/0002-9149(82)90244-2 1:STN:280:DyaL383gtlWjtQ%3D%3D (Pubitemid 12003478)
21. DI Lee S Vahebi C Gabriele CG Tocchetti LA Barouch RJ Solaro E Takimoto DA Kass 2010 PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation Basic Res Cardiol 105 337 347 10.1007/s00395-010-0084-5 20107996 10.1007/s00395-010-0084-5 1:CAS:528:DC%2BC3cXis1yhsb4%3D
22. MJ Lenzen E Boersma WJ Reimer AH Balk M Komajda K Swedberg F Follath M Jimenez-Navarro ML Simmons J Cleland 2005 Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur Heart J 26 2706 2713 10.1093/eurheartj/ehi499 16183692 10.1093/eurheartj/ehi499 1:CAS:528:DC%2BD28Xnt1yrtg%3D%3D (Pubitemid 41748284)
23. U Lotze S Kaepplinger A Kober B Richartz D Gottschild HR Figulla 2001 Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake J Nucl Med 42 49 54 11197980 1:CAS:528:DC%2BD3MXhtF2nsbg%3D (Pubitemid 32104777)
24. DM Mancini A Beniaminovitz H Levin K Catanese M Flannery M DiTullio S Savin ME Cordisco E Rose M Oz 1998 Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 98 2383 2389 10.1161/01.CIR.98.22.2383 9832482 1:STN:280:DyaK1M%2FltFGiug%3D%3D (Pubitemid 28549781)
25. S Maybaum D Mancini S Xydas RC Starling K Aaronson FD Pagani LW Miller K Margulies S McRee OH Frazier G Torre-Amione For the LVAD Working Group 2007 Cardiac improvement during mechanical circulatory support. A prospective multicenter study of the LVAD working group Circulation 115 2497 2505 10.1161/CIRCULATIONAHA.106.633180 17485581 10.1161/CIRCULATIONAHA.106.633180 (Pubitemid 46763223)
26. DH MacIver 2010 Is remodeling the dominant compensatory mechanism in both chronic heart failure with preserved and reduced left ventricular ejection fraction Basic Res Cardiol 105 227 234 10.1007/s00395-009-0063-x 19779757 10.1007/s00395-009-0063-x
27. M Metra R Giubbini S Nodari E Boldi MG Modena L Dei Cas 2000 Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol Circulation 102 546 551 10.1161/01.CIR.102.5.546 10920067 1:CAS:528:DC%2BD3cXlvFKhur0%3D (Pubitemid 30642529)
28. GR Norton AJ Woodiwiss WH Gaasch T Mela ES Chung GP Aurigemma TE Meyer 2002 Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction J Am Coll Cardiol 39 664 671 10.1016/S0735-1097(01)01792-2 11849866 10.1016/S0735-1097(01)01792-2 (Pubitemid 34158163)
29. OE Osadchii GR Norton R McKechnie D Deftereos AJ Woodiwiss 2007 Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation Am J Physiol Heart Circ Physiol 292 H1898 H1905 10.1152/ajpheart.00740.2006 17158652 10.1152/ajpheart.00740. 2006 1:CAS:528:DC%2BD2sXks1Kis7s%3D (Pubitemid 46572414)
30. PA Poole-Wilson K Swedberg JG Cleland A Di Lenarda P Hanrath M Komajda J Lubsen B Lutiger M Metra WJ Remme C Torp-Pederson A Scherhag A Skene 2003 Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 7 13 10.1016/S0140-6736(03)13800-7 12853193 10.1016/S0140-6736(03)13800-7 1:CAS:528:DC%2BD3sXltF2isrs%3D (Pubitemid 36835815)
31. PS Rahko 2005 An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy Echocardiography 22 547 554 10.111/j.1540-8175.2005.40057.X 16060890 10.1111/j.1540-8175.2005.40057.x (Pubitemid 41603160)
32. DJ Sahn A De Maria J Kisslo A Weyman 1978 Recommendations regarding quantitation of M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1072 1083 709763 1:STN:280:DyaE1M%2Fktl2msw%3D%3D (Pubitemid 9091990)
33. 2 receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade Basic Res Cardiol 105 787 794 10.1007/s00395-010-0119-y 10.1007/s00395-010-0119-y
34. JR Teerlink JM Pfeffer MA Pfeffer 1994 Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats Circ Res 75 105 113 8013068 1:STN:280:DyaK2c3ot1yksQ%3D%3D
35. RS Vasan MG Larson EJ Benjamin JC Evans D Levy 1997 Left ventricular dilation and the risk of congestive heart failure in people without myocardial infarction N Engl J Med 336 1350 1355 10.1056/NEJM199705083361903 9134875 10.1056/NEJM199705083361903 1:STN:280:DyaK2s3mtlCgtA%3D%3D (Pubitemid 27208618)
36. DG Veliotes AJ Woodiwiss DA Deftereos D Gray O Osadchii GR Norton 2005 Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation Hypertension 45 914 920 10.1161/01.HYP.0000164567.62172.c5 15837836 10.1161/01.HYP.0000164567.62172.c5 1:CAS:528:DC%2BD2MXjtlylsrY%3D (Pubitemid 40628937)
37. F Waagstein K Caidahl I Wallentin CH Bergh A Hjalmarson 1989 Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol Circulation 80 551 563 10.1161/01.CIR.80.3.551 2548768 10.1161/01.CIR.80.3.551 1:STN:280:DyaL1MzlsFensw%3D%3D (Pubitemid 19231389)
38. F Waagstein O Stromblad B Andersson M Bohm M Darius W Delius F Goss KJ Osterziel M Sigmund SP Trenkwalder I Wahlqvist 2003 Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy Eur J Heart Fail 5 679 691 10.1016/S1388-9842(03)00105-3 14607208 10.1016/S1388-9842(03)00105-3 1:CAS:528:DC%2BD3sXos1Oksrw%3D (Pubitemid 38043974)
39. KT Weber J Janicki SG Schroff R Pick RM Chen G Abrahams RI Bashey 1988 Collagen remodeling of the pressure-overloaded hypertrophied non-human primate myocardium Circ Res 62 757 765 2964945 1:CAS:528:DyaL1cXitVamu7o%3D
40. AJ Woodiwiss OJ Tsotetsi S Sprott EJ Lancaster T Mela ES Chung TE Meyer GR Norton 2001 Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction Circulation 103 155 160 10.1161/01.CIR.103.1.155 11136701 1:CAS:528:DC%2BD3MXhtFelt7Y%3D (Pubitemid 32050451)
41. MG Yussman T Toyokawa A Odley RA Lynch G Wu MC Colbert BJ Aronow JN Lorenz GW Dorn 2002 Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy Nat Med 8 725 730 10.1038/nm719 12053174 1:CAS:528:DC%2BD38XkvFehsLY%3D (Pubitemid 34778726)